Taking Mounjaro with Sertraline: what you need to know

No direct drug-drug interaction between tirzepatide and sertraline is currently documented, but absorption timing may be affected by slowed gastric emptying.
Sertraline is a widely used SSRI antidepressant; both medicines are prescription-only and require clinical oversight when taken together.
Your prescriber needs a full medicines list, including antidepressants, before starting or adjusting Mounjaro.
Any changes to mood, appetite or wellbeing on a new weight-loss treatment should be reported to a clinician promptly.

Mounjaro and sertraline are not known to interact directly, and many people take both medicines without problems. No pharmacokinetic drug-drug interaction between tirzepatide and sertraline has been identified in clinical studies. That said, because Mounjaro slows gastric emptying, it can affect how quickly other oral medicines are absorbed — and a prescriber should know about every medicine you take before tirzepatide is started. These are prescription-only medicines; clinical assessment decides what's appropriate for you.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

How Mounjaro affects other oral medicines — and what that means for sertraline

You take sertraline every morning. Now someone's mentioned Mounjaro. Here's the honest picture.

It's a reasonable concern. You've built a routine around your antidepressant (tablet beside the kettle, same time each day) and the last thing you want is a new medicine disrupting that. The good news is that the published clinical data for tirzepatide (the medicine in Mounjaro) does not flag a direct pharmacological interaction with sertraline. The two medicines work through completely different pathways: sertraline acts on serotonin reuptake in the brain; tirzepatide activates GIP and GLP-1 receptors in the gut and pancreas.

Where the nuance comes in is gastric emptying. Tirzepatide slows how quickly food and liquid leave the stomach, and that mechanism can also delay the absorption of oral medicines taken at the same time. For most drugs this is a modest, clinically insignificant effect. Sertraline is generally well absorbed, and no specific evidence suggests clinically meaningful interference. Still, if you notice any change in how your sertraline seems to be working after starting Mounjaro, that's worth raising with your GP or prescriber, not because it's expected, but because your clinical team should know.

The NHS patient information page for tirzepatide lists medicines that need particular attention alongside it, and the Mounjaro SmPC includes guidance on oral contraceptives specifically because of this gastric-emptying effect. Sertraline does not appear on that list of drugs requiring additional caution, but the underlying principle (tell your prescriber what you take) holds for every oral medicine.

Mental health, appetite and weight: the overlap worth understanding

Depression and weight are connected in ways that matter here. Sertraline can, in some people, affect appetite or weight itself; tirzepatide significantly reduces appetite through its action on hunger-regulating hormones. Taking both means your body is receiving two influences on eating behaviour simultaneously. For most people this isn't a problem. Some people find the combination makes eating feel even less appealing in the early weeks, which is worth monitoring so you maintain adequate nutrition and protein.

There is also a broader question that comes up occasionally: GLP-1 medicines and mood. Current evidence does not establish that tirzepatide causes depression or worsens existing mental health conditions, and the MHRA's ongoing monitoring programme has not flagged this as an established risk for Mounjaro specifically. The NHS tirzepatide medicine guide notes that any low mood or thoughts of self-harm should be reported to a clinician straight away, not because they are common, but because any new or worsening symptoms during treatment deserve attention.

If you're managing your mental health with sertraline and considering Mounjaro, that context is genuinely useful for a prescriber to have. It shapes the conversation about starting dose, titration timing and what to watch for. It doesn't automatically exclude you; it informs the assessment.

What your prescriber needs to know, and why it matters for this specific combination

When you apply for Mounjaro through a clinician-led service, you'll be asked about all current medicines. Sertraline belongs on that list. A fuller picture of who Mounjaro is suitable for covers the main contraindications and conditions that affect eligibility, but co-prescribing with antidepressants isn't an automatic barrier, it's a data point a prescriber uses to make a better decision.

It's worth knowing that the eligibility criteria for Mounjaro under its UK licence are BMI 30 or above, or BMI 27 or above alongside at least one weight-related health condition. You can get a sense of where you sit using the NHS BMI calculator, and our BMI and Mounjaro eligibility guide explains how those thresholds apply in practice. If you're unsure whether your BMI meets the threshold, our guide on starting Mounjaro with a lower BMI explains how that situation is assessed. The prescriber considers the whole picture, not just BMI, not just your medicines list, but both together.

Questions about other medicines alongside Mounjaro come up regularly. If antidepressants are your concern, you may also find it useful to read about taking amitriptyline with Mounjaro, which covers another commonly prescribed medication in a similar vein. And if you're weighing up your options more broadly, our weight-loss treatment overview sets out the choices available.

For context on cost, the Mounjaro pricing guide explains what private treatment typically involves and what to factor in when comparing providers.

Ready to talk it through properly? If you'd like to understand how getting Mounjaro online works, including what the consultation process involves and what to expect at each step, that page walks you through it. Speak to our prescribers, your consultation is free, reviewed the same day by a named GPhC-registered prescriber, and your medicines list is part of that conversation from the start.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions